Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Colorectal Cancer T4: Should Prophylactic HIPEC be Performed?Annals of surgical oncology, 2023-04, Vol.30 (4), p.2532-2533 [Peer Reviewed Journal]Society of Surgical Oncology 2023. ;ISSN: 1068-9265 ;EISSN: 1534-4681 ;DOI: 10.1245/s10434-023-13100-7Full text available |
|
2 |
Material Type: Article
|
ASO Visual Abstract: Molecular Basis of Extramural Vascular Invasion (EMVI) in Colorectal CarcinomaAnnals of surgical oncology, 2022-11, Vol.29 (12), p.7384-7385 [Peer Reviewed Journal]Society of Surgical Oncology 2022. ;ISSN: 1068-9265 ;EISSN: 1534-4681 ;DOI: 10.1245/s10434-022-12343-0Full text available |
|
3 |
Material Type: Article
|
Correction to: N6‑methyladenosine levels in peripheral blood RNA: a potential diagnostic biomarker for colorectal cancerCancer cell international, 2024-04, Vol.24 (1), p.126-126 [Peer Reviewed Journal]2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1475-2867 ;EISSN: 1475-2867 ;DOI: 10.1186/s12935-024-03303-7 ;PMID: 38581005Full text available |
|
4 |
Material Type: Article
|
Author Correction: Deregulation of the miR-16-KRAS axis promotes colorectal cancerScientific reports, 2021-09, Vol.11 (1), p.19841-19841, Article 19841 [Peer Reviewed Journal]The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 2045-2322 ;EISSN: 2045-2322 ;DOI: 10.1038/s41598-021-99119-w ;PMID: 34593955Full text available |
|
5 |
Material Type: Article
|
Correction: Interaction between laminin-5γ2 and integrin β1 promotes the tumor budding of colorectal cancer via the activation of Yes-associated proteinsOncogene, 2022-09, Vol.41 (38), p.4405-4406 [Peer Reviewed Journal]The Author(s), under exclusive licence to Springer Nature Limited 2022. ;ISSN: 0950-9232 ;EISSN: 1476-5594 ;DOI: 10.1038/s41388-022-02422-7Full text available |
|
6 |
Material Type: Article
|
Correction: External validation of risk prediction models for incident colorectal cancer using UK BiobankBritish journal of cancer, 2020-05, Vol.122 (10), p.1572-1575 [Peer Reviewed Journal]The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/s41416-020-0767-0 ;PMID: 32203217Full text available |
|
7 |
Material Type: Article
|
Correction: miR-27a is a master regulator of metabolic reprogramming and chemoresistance in colorectal cancerBritish journal of cancer, 2020-05, Vol.122 (10), p.1576-1576 [Peer Reviewed Journal]The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/s41416-020-0855-1 ;PMID: 32303716Full text available |
|
8 |
Material Type: Article
|
Correction: A multicentre, prospective study of plasma circulating tumour DNA test for detecting RAS mutation in patients with metastatic colorectal cancerBritish journal of cancer, 2020-04, Vol.122 (8), p.1271-1271 [Peer Reviewed Journal]The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/s41416-020-0766-1 ;PMID: 32099097Full text available |
|
9 |
Material Type: Article
|
Featured CoverImmunology, 2023-01, Vol.168 (1), p.i-i [Peer Reviewed Journal]2023 John Wiley & Sons Ltd. ;ISSN: 0019-2805 ;EISSN: 1365-2567 ;DOI: 10.1111/imm.13616Full text available |
|
10 |
Material Type: Article
|
Correction: Transdifferentiation of tumor infiltrating innate lymphoid cells during progression of colorectal cancerCell research, 2020-07, Vol.30 (7), p.630-630 [Peer Reviewed Journal]Center for Excellence in Molecular Cell Science, CAS 2020. ;Center for Excellence in Molecular Cell Science, CAS 2020 ;ISSN: 1001-0602 ;EISSN: 1748-7838 ;DOI: 10.1038/s41422-020-0352-3 ;PMID: 32541864Full text available |
|
11 |
Material Type: Article
|
Retracted: Identification of a 5-Nutrient Stress-Sensitive Gene Signature to Predict Survival for Colorectal CancerBioMed research international, 2024, Vol.2024, p.9823079-9823079 [Peer Reviewed Journal]Copyright © 2024 BioMed Research International. ;Copyright © 2024 BioMed Research International. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. https://creativecommons.org/licenses/by/4.0 ;Copyright © 2024 BioMed Research International. 2024 ;ISSN: 2314-6133 ;EISSN: 2314-6141 ;DOI: 10.1155/2024/9823079 ;PMID: 38550151Full text available |
|
12 |
Material Type: Article
|
Retracted: circZC3HAV1 Regulates TBC1D9 to Affect the Biological Behavior of Colorectal Cancer CellsBioMed research international, 2024, Vol.2024, p.9892656-9892656 [Peer Reviewed Journal]Copyright © 2024 BioMed Research International. ;Copyright © 2024 BioMed Research International. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. https://creativecommons.org/licenses/by/4.0 ;Copyright © 2024 BioMed Research International. 2024 ;ISSN: 2314-6133 ;EISSN: 2314-6141 ;DOI: 10.1155/2024/9892656 ;PMID: 38550177Full text available |
|
13 |
Material Type: Article
|
Correction: O-GlcNAcylation promotes colorectal cancer metastasis via the miR-101-O-GlcNAc/EZH2 regulatory feedback circuitOncogene, 2019-07, Vol.38 (28), p.5744-5745 [Peer Reviewed Journal]COPYRIGHT 2019 Nature Publishing Group ;The Author(s), under exclusive licence to Springer Nature Limited 2019. ;The Author(s), under exclusive licence to Springer Nature Limited 2019 ;ISSN: 0950-9232 ;EISSN: 1476-5594 ;DOI: 10.1038/s41388-019-0834-2 ;PMID: 31160652Full text available |
|
14 |
Material Type: Article
|
Author Correction: Germline susceptibility variants impact clinical outcome and therapeutic strategies for stage III colorectal cancerScientific reports, 2020-07, Vol.10 (1), p.12216-12216, Article 12216 [Peer Reviewed Journal]The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 2045-2322 ;EISSN: 2045-2322 ;DOI: 10.1038/s41598-020-69145-1 ;PMID: 32678259Full text available |
|
15 |
Material Type: Article
|
Correction: A phase 2 randomised study of veliparib plus FOLFIRI±bevacizumab versus placebo plus FOLFIRI±bevacizumab in metastatic colorectal cancerBritish journal of cancer, 2019-07, Vol.121 (5), p.429-430 [Peer Reviewed Journal]2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2019 ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/s41416-019-0528-0 ;PMID: 31350526Full text available |
|
16 |
Material Type: Article
|
Detection of Different Tissue Types of Colorectal Cancer Based on Histological Images Using Deep Learning ApproachTürkiye klinikleri bıyoıstatıstık, 2021-07, Vol.13 (2), p.147-159 [Peer Reviewed Journal]Copyright Ortadogu Reklam Tanitim Yayincilik Turizm Egitim Insaat Sanayi ve Ticaret A.S. 2021 ;ISSN: 1308-7894 ;EISSN: 2146-8877 ;DOI: 10.5336/biostatic.2021-82416Full text available |
|
17 |
Material Type: Article
|
Correction to: miR-375- and miR-1-Regulated Coxsackievirus B3 Has No Pancreas and Heart Toxicity But Strong Antitumor Efficiency in Colorectal Carcinomas by Ahmet Hazini et al . Hum Gene Ther 2021;32:216-230. DOI: 10.1089/hum.2020.228Human gene therapy, 2021-02, Vol.32 (3-4), p.231-231 [Peer Reviewed Journal]Copyright Mary Ann Liebert, Inc. Feb 2021 ;ISSN: 1043-0342 ;EISSN: 1557-7422 ;DOI: 10.1089/hum.2020.228.correx ;PMID: 33621142Full text available |
|
18 |
Material Type: Article
|
Prostate Cancer Mortality-To-Incidence Ratios Are Associated with Cancer Care Disparities in 35 CountriesScientific reports, 2017-01, Vol.7 (1), p.40003-40003, Article 40003 [Peer Reviewed Journal]Copyright Nature Publishing Group Jan 2017 ;Copyright © 2017, The Author(s) 2017 The Author(s) ;ISSN: 2045-2322 ;EISSN: 2045-2322 ;DOI: 10.1038/srep40003 ;PMID: 28051150Full text available |
|
19 |
Material Type: Article
|
Corrigendum: Colonic organoids derived from human induced pluripotent stem cells for modeling colorectal cancer and drug testingNature medicine, 2018-04, Vol.24 (4), p.526-526 [Peer Reviewed Journal]COPYRIGHT 2018 Nature Publishing Group ;COPYRIGHT 2018 Nature Publishing Group ;Copyright Nature Publishing Group Apr 2018 ;ISSN: 1078-8956 ;EISSN: 1546-170X ;DOI: 10.1038/nm0418-526a ;PMID: 29634683Full text available |
|
20 |
Material Type: Article
|
IDDF2022-ABS-0206 Recurrence of advanced colorectal neoplasia in subjects with baseline non-advanced neoplasia: a comparison cohort studyGut, 2022-09, Vol.71 (Suppl 2), p.A158-A159 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;2022 Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 0017-5749 ;EISSN: 1468-3288 ;DOI: 10.1136/gutjnl-2022-IDDF.223Full text available |